Evidence map›Paper›PMID 30728054›Full record

ArticleJournal of experimental & clinical cancer research : CR2019

SNHG1 promotes malignant biological behaviors of glioma cells via microRNA-154-5p/miR-376b-3p- FOXP2- KDM5B participating positive feedback loop.

Han Li, Yixue Xue, Jun Ma, Lianqi Shao, Di Wang, Jian Zheng, Xiaobai Liu, Chunqing Yang, Qianru He, Xuelei Ruan and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. FOXP2/SOS1/AKT negative feedback loop inhibits cell proliferation in KRAS-mutant colorectal cancer.Apoptosis : an international journal on programmed cell death · 2025
    Article
  2. Article
  3. Article
  4. CDK5: Insights into its roles in diseases.Molecular biology reports · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Han LiDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, People's Republic of China.
Yixue XueDepartment of Neurobiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning, 110122, People's Republic of China.
Jun MaDepartment of Neurobiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning, 110122, People's Republic of China.
Lianqi ShaoDepartment of Neurobiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning, 110122, People's Republic of China.
Di WangDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, People's Republic of China.
Jian ZhengDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, People's Republic of China.
Xiaobai LiuDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, People's Republic of China.
Chunqing YangDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, People's Republic of China.
Qianru HeDepartment of Neurobiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning, 110122, People's Republic of China.
Xuelei RuanDepartment of Neurobiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning, 110122, People's Republic of China.
Zhen LiDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, People's Republic of China.
Yunhui LiuDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, People's Republic of China. liuyh_cmuns@163.com.
China Medical University · CN

Funding

Liaoning Science and Technology Plan Project 2015225007National Natural Science Foundation of China 81573010National Natural Science Foundation of China 81672511outstanding scientific fund of Shengjing hospital 201304special developmental project guided by central government of Liaoning Province 2017011553-301
6 · The paper itself

Abstract

backgroundLong non-coding RNAs has been reported in tumorigenesis and play important roles in regulating malignant behavior of cancers, including glioma.

methodsAccording to the TCGA database, we identified SNHG1, miRNA-154-5p and miR-376b-3p whose expression were significantly changed in the glioma samples. Furthermore, we investigated SNHG1, miRNA-154-5p and miR-376b-3p expression in clinical samples and glioma cell lines using qRT-PCR analysis and the correlation between them using RNA immunoprecipitation and dual-luciferase reporter. The underlying mechanisms of SNHG1 in glioma were also investigated using immunohistochemistry staining, Western blotting, chromatin immunoprecipitation, and RNA pulldown. Cell Counting Kit-8, transwell assays, and flow cytometry were used to investigate malignant biological behaviors.

resultsWe have elucidated the potential molecular mechanism of long non-coding RNA SNHG1 regulating the malignant behavior of glioma cells by binding to microRNA-154-5p or miR-376b-3p. Moreover, our deep-going results showed that FOXP2 existed as a direct downstream target of both microRNA-154-5p and miR-376b-3p; FOXP2 increased promoter activities and enhanced the expression of the oncogenic gene KDM5B; and KDM5B also acts as a RNA-binding protein to maintain the stability of SNHG1.

conclusionCollectively, this study demonstrates that the SNHG1- microRNA-154-5p/miR-376b-3p- FOXP2- KDM5B feedback loop plays a pivotal role in regulating the malignant behavior of glioma cells.

Indexed as

Feedback, PhysiologicalAnimalsCarcinogenesisCell Line, TumorCentral Nervous System NeoplasmsForkhead Transcription FactorsGene Expression Regulation, NeoplasticGliomaHumansJumonji Domain-Containing Histone DemethylasesMiceMicroRNAsNuclear ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRepressor ProteinsForkhead Transcription FactorsFOXP2 protein, humanJumonji Domain-Containing Histone DemethylasesKDM5B protein, humanlong non-coding RNA SNHG1, humanMicroRNAsMIRN154 microRNA, humanMIRN376C microRNA, humanNuclear ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRepressor ProteinsRNA, Long NoncodingGliomaLong non-coding RNAmicroRNAOncogenesTranscription factor

Identifiers

PMID30728054
PMCPMC6364475
OpenAlexW2917651758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.